The findings from the in vivo assay are consistent with those observed in vitro and suggest that the IL‐10–IL‐10R pathway may enhance angiogenesis by acting on at least two cell types, endometriotic cells and vessel endothelial cells, in the context of endometriosis. Here, IL10 is linked to endometriosis.